Questions & Answers | Numbers | Proportions |
---|---|---|
Q1. For eligible ischemic stroke patients, what is the recommended time window for intravenous fibrinolytic therapy with rtPA? | ||
3 hours | 686 | 35.9 % |
4 hours | 180 | 9.4 % |
4.5 hoursb | 275 | 14.4 % |
6 hours | 769 | 40.3 % |
Q2. In secondary prevention for ischemic stroke or TIA, which of the following antihypertensive recommendations should be used in patients with elevated blood pressure? | ||
20/15 mmHg | 330 | 17.3 % |
15/10 mmHg | 600 | 31.4 % |
10/5 mmHgb | 945 | 49.5 % |
5/0 mmHg | 35 | 1.8 % |
Q3. If necessary to prevent recurrent stroke or other vascular events in ischemic stroke or TIA patients, when is it recommended to initiate antihypertensive therapy? | ||
Immediately | 344 | 18.0 % |
Beyond 24 hoursb | 1,112 | 58.2 % |
Beyond 1 week | 260 | 13.6 % |
Beyond 2 weeks | 194 | 10.2 % |
Q4. What is the approximate percentage of cardiogenic cerebral embolism in all ischemic strokes? | ||
5 % | 319 | 16.7 % |
10 % | 386 | 20.2 % |
15 % | 405 | 21.2 % |
20%b | 800 | 41.9 % |
Q5. For ischemic stroke or TIA patients with AF, what is the recommended first-choice medication, if no contraindication exists? | ||
Antiplatelet medication | 524 | 27.4 % |
Oral anticoagulantb | 1,247 | 65.3 % |
Defibrase | 105 | 5.5 % |
Others, i.e., traditional Chinese medicine | 34 | 1.8 % |
Q6. What is the target INR for ischemic stroke or TIA patients with AF receiving anticoagulation with a vitamin K antagonist? | ||
1–2 | 180 | 9.4 % |
2–3b | 1,507 | 78.9 % |
3–4 | 195 | 10.2 % |
4–5 | 28 | 1.5 % |
Q7. For ischemic stroke or TIA patients with AF who are unable to take oral anticoagulants, what medication is recommended? | ||
Aspirin aloneb | 504 | 26.4 % |
Clopidogrel alone | 398 | 20.8 % |
Combination of clopidogrel and aspirin | 1,008 | 52.8 % |
Do not use any other medications | 0 | 0 |
Q8. For ischemic stroke or TIA with acute myocardial infarction complicated by left ventricular mural thrombus formation identified by echocardiography or other cardiac imaging techniques, for at least how long should the patients be treated with oral anticoagulation? | ||
3 monthsb | 514 | 26.9 % |
6 months | 760 | 39.8 % |
9 months | 120 | 6.3 % |
12 months | 516 | 27.0 % |
Q9. For ischemic stroke or TIA patients with rheumatic mitral valve disease, is long-term warfarin therapy recommended whether or not AF is present? | ||
Yesb | 1,215 | 63.6 % |
No | 487 | 25.5 % |
No idea | 208 | 10.9 % |
Q10. For patients with noncardioembolic ischemic stroke or TIA, what medications are recommended to reduce the risk of recurrent stroke and other cardiovascular events? | ||
Antiplateletsb | 1,280 | 67.0 % |
Oral anticoagulants | 29 | 26.1 % |
Traditional Chinese medicine | 131 | 6.9 % |
Q11. Is aspirin plus clopidogrel recommended for routine secondary prevention after ischemic stroke or TIA? | ||
Yes | 886 | 46.4 % |
Nob | 774 | 40.5 % |
No idea | 250 | 13.1 % |
Q12. Is there evidence that reducing homocysteine levels prevents stroke recurrence in ischemic stroke or TIA patients? | ||
Yes | 1,322 | 69.2 % |
Nob | 217 | 11.4 % |
No idea | 371 | 19.4 % |
Q13. Is postmenopausal hormone therapy recommended for women with ischemic stroke or TIA? | ||
Yes | 562 | 29.4 % |
Nob | 894 | 46.8 % |
No idea | 454 | 23.8 % |